bitcoin crypto bank Top snippets

Hongxin Electronics: Promote the technical research and development and product supply of folding mobile phone reels with Xiaomi. Hongxin Electronics officially announced today that recently, the 2024 Xiaomi Global Core Supplier Conference was held in Beijing Yanqi Lake International Convention & Exhibition Center. Under the background that Xiaomi's strategy of "people, cars and homes are all ecological" continues to deepen, Hongxin Electronics will closely follow Xiaomi's footsteps, actively expand emerging fields such as home appliances and automobiles, and provide all-round support and services in flexible electronics for Xiaomi's intelligent hardware all-ecological products. At present, in the face of the booming folding mobile phone market, Hongxin Electronics and Xiaomi jointly promote the technology research and development and product supply of folding mobile phone reels. According to reports, in the era of vigorous development of artificial intelligence and digital economy, at present, Hongxin Electronics has deeply laid out frontier fields such as AI mobile phones, AIPC, smart cars, smart homes, smart wearable devices, robots, industrial control, medical care and meta-universe.Hyundai Motor set up 200 million technology companies in Shanghai, including a number of AI-related businesses. According to Tianyancha App, Hyundai Kemo (Shanghai) Technology Co., Ltd. was recently established, with NOH YONG HO as the legal representative and a registered capital of 213 million RMB. Its business scope includes application system integration services in artificial intelligence industry, Internet of Things application services, data processing services, artificial intelligence basic software development, artificial intelligence application software development, artificial intelligence theory and algorithm software development, etc. According to shareholder information, the company is wholly owned by Hyundai Motor Co., Ltd.Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.

The head of the region said that the Russian attack on the key infrastructure in the Ivano-Frankov region was the biggest attack on the region so far.On the 13th, glass fell by 2.14%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract glass closed at 2505, up or down by -2.14%, with a turnover of 671,300 lots. The position data showed that the top 20 seats were clear, and the difference position was 46,081 lots. The total turnover of glass futures contracts was 999,900 lots, an increase of 189,100 lots over the previous day. The first 20 seats in the contract held 565,600 lots, a decrease of 12,000 lots from the previous day. The short positions in the top 20 seats of the contract were 661,500 lots, a decrease of 13,600 lots from the previous day. (Sina Futures)Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.

Hongxin Electronics: Promote the technical research and development and product supply of folding mobile phone reels with Xiaomi. Hongxin Electronics officially announced today that recently, the 2024 Xiaomi Global Core Supplier Conference was held in Beijing Yanqi Lake International Convention & Exhibition Center. Under the background that Xiaomi's strategy of "people, cars and homes are all ecological" continues to deepen, Hongxin Electronics will closely follow Xiaomi's footsteps, actively expand emerging fields such as home appliances and automobiles, and provide all-round support and services in flexible electronics for Xiaomi's intelligent hardware all-ecological products. At present, in the face of the booming folding mobile phone market, Hongxin Electronics and Xiaomi jointly promote the technology research and development and product supply of folding mobile phone reels. According to reports, in the era of vigorous development of artificial intelligence and digital economy, at present, Hongxin Electronics has deeply laid out frontier fields such as AI mobile phones, AIPC, smart cars, smart homes, smart wearable devices, robots, industrial control, medical care and meta-universe.Shanghai ranks third in the world! The Global Financial Technology Center Development Index (2024) was released. It was learned from the 6th Shanghai International Forum on Financial Technology that the Shanghai Financial Technology Industry Alliance released the "Global Financial Technology Center Development Index (2024)", which was released for the second consecutive year. The results of this index show that new york, London, Shanghai, Beijing, Shenzhen, Tokyo, Chicago, Hong Kong, Singapore and San Francisco rank among the top ten in the world. The index is mainly composed of indicators such as the development level, development potential and development environment of financial technology, which intuitively reflects the development of financial technology in different cities around the world in quantitative form. Compared with the previous index, the list of the top ten cities remains unchanged, but the gap between the index scores of cities has further narrowed, showing the increasingly fierce competition in the development of financial technology in major cities around the world. (CBN)The annual evaluation report of the big model in the financial field was released, and the big model of Step Star/Fortune Leap Star performed well. The 6th Shanghai International Forum on Financial Technology was held in Shanghai. At the meeting, Shanghai Artificial Intelligence Laboratory, together with Shanghai University of Finance and Economics and Shanghai Cooper Technology Co., Ltd., released the Report on Evaluation of Large Models in Financial Field (2024), which comprehensively evaluated 20 models from five dimensions: model basic ability, financial security and value alignment ability, financial risk control ability, financial professional cognitive ability and financial business auxiliary expansion ability. The comprehensive scores of Anthropic, Step Star/Fortune Star and Alibaba ranked in the top three. Step-2-16k model of Step Star/Fortune Star got the second comprehensive score, and the multi-modal comprehensive score of Finstep model got the first.